Statera Biopharma, Inc.: 10-K filed 2015-02-27

Name: Statera Biopharma, Inc.: 10-K filed 2015-02-27
Creator: Statera Biopharma, Inc.

What Statera Biopharma, Inc. reported in its annual report filed 2015-02-27 (fiscal FY 2014): 39 published measures, 142 facts as tagged in accession 0001193125-15-067307.

This filing

Form: 10-K (annual report)
Filed: 2015-02-27
Fiscal period: fiscal FY 2014
Accession: 0001193125-15-067307 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Statera Biopharma, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-12-31	9,814,232	USD
At 2013-12-31	14,695,641	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-12-31	8,028,130	USD
At 2013-12-31	13,114,663	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-12-31	-1,607,397	USD
At 2013-12-31	-9,522,945	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-12-31	3,103,969	USD
At 2013-12-31	10,048,466	USD
At 2012-12-31	25,652,083	USD
At 2011-12-31	22,872,589	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	11,271,771	USD	92
2014-07-01 to 2014-09-30	-4,096,134	USD	92
2014-04-01 to 2014-06-30	-3,961,161	USD	91
2014-01-01 to 2014-03-31	-1,585,372	USD	90
2013-10-01 to 2013-12-31	-365,247	USD	92
2013-07-01 to 2013-09-30	-4,091,196	USD	92
2013-04-01 to 2013-06-30	-3,042,111	USD	91
2013-01-01 to 2013-03-31	-9,764,323	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-12-31	-133,935,562	USD
At 2013-12-31	-135,564,666	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	2,856,461	shares	92
2014-07-01 to 2014-09-30	2,855,510	shares	92
2014-04-01 to 2014-06-30	2,594,582	shares	91
2014-01-01 to 2014-03-31	2,498,407	shares	90
2013-10-01 to 2013-12-31	2,258,507	shares	92
2013-07-01 to 2013-09-30	2,253,064	shares	92
2013-04-01 to 2013-06-30	2,247,430	shares	91
2013-01-01 to 2013-03-31	2,241,329	shares	90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	2,856,461	shares	92
2014-07-01 to 2014-09-30	2,855,510	shares	92
2014-04-01 to 2014-06-30	2,594,582	shares	91
2014-01-01 to 2014-03-31	2,498,407	shares	90
2013-10-01 to 2013-12-31	2,258,507	shares	92
2013-07-01 to 2013-09-30	2,253,064	shares	92
2013-04-01 to 2013-06-30	2,247,430	shares	91
2013-01-01 to 2013-03-31	2,241,329	shares	90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	3.95	USD/shares	92
2014-07-01 to 2014-09-30	-1.43	USD/shares	92
2014-04-01 to 2014-06-30	-1.53	USD/shares	91
2014-01-01 to 2014-03-31	-0.63	USD/shares	90
2013-10-01 to 2013-12-31	-0.16	USD/shares	92
2013-07-01 to 2013-09-30	-1.82	USD/shares	92
2013-04-01 to 2013-06-30	-1.35	USD/shares	91
2013-01-01 to 2013-03-31	-4.36	USD/shares	90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	3.95	USD/shares	92
2014-07-01 to 2014-09-30	-1.43	USD/shares	92
2014-04-01 to 2014-06-30	-1.53	USD/shares	91
2014-01-01 to 2014-03-31	-0.63	USD/shares	90
2013-10-01 to 2013-12-31	-0.16	USD/shares	92
2013-07-01 to 2013-09-30	-1.82	USD/shares	92
2013-04-01 to 2013-06-30	-1.35	USD/shares	91
2013-01-01 to 2013-03-31	-4.36	USD/shares	90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2014-01-01 to 2014-12-31	USD	365
2013-01-01 to 2013-12-31	USD	365
2012-01-01 to 2012-12-31	USD	366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-12-31	244,537	USD
At 2013-12-31	457,912	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-3,451,630	USD	92
2014-01-01 to 2014-12-31	-14,421,935	USD	365
2014-07-01 to 2014-09-30	-3,438,739	USD	92
2014-04-01 to 2014-06-30	-4,012,504	USD	91
2014-01-01 to 2014-03-31	-3,519,062	USD	90
2013-10-01 to 2013-12-31	-2,996,158	USD	92
2013-01-01 to 2013-12-31	-23,076,759	USD	365
2013-07-01 to 2013-09-30	-5,856,468	USD	92
2013-04-01 to 2013-06-30	-6,776,618	USD	91
2013-01-01 to 2013-03-31	-7,447,515	USD	90
2012-01-01 to 2012-12-31	-30,046,606	USD	366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-12-31	3,545,347	USD
At 2013-12-31	11,156,781	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-12-31	6,529,080	USD
At 2013-12-31	5,985,753	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-12-31	1,057,743	USD
At 2013-12-31	794,397	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-12-31	267,199	USD
At 2013-12-31	458,391	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	18,123,834	USD	365
2013-01-01 to 2013-12-31	31,564,725	USD	365
2012-01-01 to 2012-12-31	33,617,316	USD	366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	9,654,144	USD	365
2013-01-01 to 2013-12-31	19,525,950	USD	365
2012-01-01 to 2012-12-31	22,501,805	USD	366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-12-31	2,858,126	shares
At 2013-12-31	2,259,818	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-12-31	132,693,988	USD
At 2013-12-31	125,723,083	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-12-31	-380,110	USD
At 2013-12-31	307,339	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2014-12-31	1,786,102	USD
At 2013-12-31	1,580,978	USD
At 2012-12-31	20,485,708	USD
At 2011-12-31	22,245,496	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2014-12-31	1,499,050	USD
At 2013-12-31	7,121,388	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2014-12-31	1,885,149	USD
At 2013-12-31	1,944,656	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2014-12-31	1,640,612	USD
At 2013-12-31	1,486,744	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-12-31	56,131	USD
At 2013-12-31	159,224	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-12-31	1,804,456	USD
At 2013-12-31	2,445,446	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2014-12-31	0	USD
At 2013-12-31	0	USD
At 2012-12-31	0	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	10,683,797	USD	92
2014-01-01 to 2014-12-31	35,366	USD	365
2014-07-01 to 2014-09-30	-4,615,663	USD	92
2014-04-01 to 2014-06-30	-4,131,571	USD	91
2014-01-01 to 2014-03-31	-1,901,197	USD	90
2013-10-01 to 2013-12-31	-844,754	USD	92
2013-01-01 to 2013-12-31	-20,129,284	USD	365
2013-07-01 to 2013-09-30	-4,610,961	USD	92
2013-04-01 to 2013-06-30	-3,886,421	USD	91
2013-01-01 to 2013-03-31	-10,787,148	USD	90
2012-01-01 to 2012-12-31	-22,414,640	USD	366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	695,995	USD	365
2013-01-01 to 2013-12-31	-17,502,011	USD	365
2012-01-01 to 2012-12-31	-17,772,282	USD	366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	1,629,104	USD	365
2013-01-01 to 2013-12-31	-17,262,877	USD	365
2012-01-01 to 2012-12-31	-18,234,142	USD	366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	8,469,690	USD	365
2013-01-01 to 2013-12-31	12,038,775	USD	365
2012-01-01 to 2012-12-31	11,115,511	USD	366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	200,792	USD	365
2013-01-01 to 2013-12-31	376,213	USD	365
2012-01-01 to 2012-12-31	479,595	USD	366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	-1,089,582	USD	365
2013-01-01 to 2013-12-31	44,925	USD	365
2012-01-01 to 2012-12-31	295,123	USD	366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	14,457,301	USD	365
2013-01-01 to 2013-12-31	2,947,475	USD	365
2012-01-01 to 2012-12-31	7,631,966	USD	366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	9,697,501	USD	365
2012-01-01 to 2012-12-31	15,675,727	USD	366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	-629,397	USD	365
2013-01-01 to 2013-12-31	416,495	USD	365
2012-01-01 to 2012-12-31	-1,736,199	USD	366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-12-31	459,337	USD	365
2013-01-01 to 2013-12-31	-713,502	USD	365
2012-01-01 to 2012-12-31	609,522	USD	366

Inspect the source

Entity: Statera Biopharma, Inc. / CIK 0001318641
Captured: 2026-09-22 19:44 UTC
SEC response SHA-256: 9e499247f86d1cf9ca87ba87bfcdf37d42baa7907f4baa6e983f1992a49045f7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001318641.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))